These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 31253705
1. Optimal control strategies for inhibition of protein aggregation. Michaels TCT, Weber CA, Mahadevan L. Proc Natl Acad Sci U S A; 2019 Jul 16; 116(29):14593-14598. PubMed ID: 31253705 [Abstract] [Full Text] [Related]
5. An anticancer drug suppresses the primary nucleation reaction that initiates the production of the toxic Aβ42 aggregates linked with Alzheimer's disease. Habchi J, Arosio P, Perni M, Costa AR, Yagi-Utsumi M, Joshi P, Chia S, Cohen SI, Müller MB, Linse S, Nollen EA, Dobson CM, Knowles TP, Vendruscolo M. Sci Adv; 2016 Feb 16; 2(2):e1501244. PubMed ID: 26933687 [Abstract] [Full Text] [Related]
6. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif. Kino R, Araya T, Arai T, Sohma Y, Kanai M. Bioorg Med Chem Lett; 2015 Aug 01; 25(15):2972-5. PubMed ID: 26045033 [Abstract] [Full Text] [Related]
7. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds. Dong M, Zhao W, Hu D, Ai H, Kang B. ACS Chem Neurosci; 2017 Jul 19; 8(7):1577-1588. PubMed ID: 28406293 [Abstract] [Full Text] [Related]
9. Inhibition of amyloid-β aggregation in Alzheimer's disease. Wang Q, Yu X, Li L, Zheng J. Curr Pharm Des; 2014 Jul 19; 20(8):1223-43. PubMed ID: 23713775 [Abstract] [Full Text] [Related]
10. RTHLVFFARK-NH2: A potent and selective modulator on Cu2+-mediated amyloid-β protein aggregation and cytotoxicity. Meng J, Zhang H, Dong X, Liu F, Sun Y. J Inorg Biochem; 2018 Apr 19; 181():56-64. PubMed ID: 29407908 [Abstract] [Full Text] [Related]
13. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers. Klein AN, Ziehm T, van Groen T, Kadish I, Elfgen A, Tusche M, Thomaier M, Reiss K, Brener O, Gremer L, Kutzsche J, Willbold D. ACS Chem Neurosci; 2017 Sep 20; 8(9):1889-1900. PubMed ID: 28581708 [Abstract] [Full Text] [Related]
14. 1,2-Diaryl-2-hydroxyiminoethanones as dual COX-1 and β-amyloid aggregation inhibitors: biological evaluation and in silico study. Irannejad H, Unsal Tan O, Ozadali K, Dadashpour S, Tuylu Kucukkilinc T, Ahangar N, Ahmadnejad M, Emami S. Chem Biol Drug Des; 2015 Apr 20; 85(4):494-503. PubMed ID: 25227162 [Abstract] [Full Text] [Related]
15. Photo-induced inhibition of Alzheimer's β-amyloid aggregation in vitro by rose bengal. Lee JS, Lee BI, Park CB. Biomaterials; 2015 Jan 20; 38():43-9. PubMed ID: 25457982 [Abstract] [Full Text] [Related]
16. Polyoxometalates as inhibitors of the aggregation of amyloid β peptides associated with Alzheimer's disease. Geng J, Li M, Ren J, Wang E, Qu X. Angew Chem Int Ed Engl; 2011 Apr 26; 50(18):4184-8. PubMed ID: 21433228 [No Abstract] [Full Text] [Related]
18. Modulating amyloid-β aggregation: The effects of peptoid side chain placement and chirality. Turner JP, Chastain SE, Park D, Moss MA, Servoss SL. Bioorg Med Chem; 2017 Jan 01; 25(1):20-26. PubMed ID: 27776890 [Abstract] [Full Text] [Related]
19. (-)-Meptazinol-melatonin hybrids as novel dual inhibitors of cholinesterases and amyloid-β aggregation with high antioxidant potency for Alzheimer's therapy. Cheng S, Zheng W, Gong P, Zhou Q, Xie Q, Yu L, Zhang P, Chen L, Li J, Chen J, Chen H, Chen H. Bioorg Med Chem; 2015 Jul 01; 23(13):3110-8. PubMed ID: 26025073 [Abstract] [Full Text] [Related]
20. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway. Di Carlo MG, Minicozzi V, Foderà V, Militello V, Vetri V, Morante S, Leone M. Biophys Chem; 2015 Nov 01; 206():1-11. PubMed ID: 26100600 [Abstract] [Full Text] [Related] Page: [Next] [New Search]